NanoViricides Statistics

Total Valuation

NanoViricides has a market cap or net worth of $21.38 million. The enterprise value is $17.51 million.

Market Cap	21.38M
Enterprise Value	17.51M

Important Dates

The next estimated earnings date is Wednesday, February 12, 2025, after market close.

Earnings Date	Feb 12, 2025
Ex-Dividend Date	n/a

Share Statistics

NanoViricides has 14.35 million shares outstanding. The number of shares has increased by 6.11% in one year.

Current Share Class	14.35M
Shares Outstanding	14.35M
Shares Change (YoY)	+6.11%
Shares Change (QoQ)	+12.06%
Owned by Insiders (%)	0.66%
Owned by Institutions (%)	9.34%
Float	13.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.07
P/TBV Ratio	2.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.48

Current Ratio	2.48
Quick Ratio	2.37
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-724.92

Financial Efficiency

Return on equity (ROE) is -81.92% and return on invested capital (ROIC) is -52.28%.

Return on Equity (ROE)	-81.92%
Return on Assets (ROA)	-44.43%
Return on Capital (ROIC)	-52.28%
Revenue Per Employee	n/a
Profits Per Employee	-$1.35M
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +33.04% in the last 52 weeks. The beta is 0.91, so NanoViricides's price volatility has been similar to the market average.

Beta (5Y)	0.91
52-Week Price Change	+33.04%
50-Day Moving Average	1.43
200-Day Moving Average	1.66
Relative Strength Index (RSI)	55.39
Average Volume (20 Days)	240,725

Short Selling Information

The latest short interest is 295,097, so 2.06% of the outstanding shares have been sold short.

Short Interest	295,097
Short Previous Month	448,955
Short % of Shares Out	2.06%
Short % of Float	2.14%
Short Ratio (days to cover)	1.64

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-9.65M
Pretax Income	-9.51M
Net Income	-9.45M
EBITDA	-8.89M
EBIT	-9.65M
Earnings Per Share (EPS)	-$0.76

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	3.87M
Total Debt	n/a
Net Cash	3.87M
Net Cash Per Share	$0.27
Equity (Book Value)	10.11M
Book Value Per Share	0.72
Working Capital	2.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.74 million and capital expenditures -$195,033, giving a free cash flow of -$7.93 million.

Operating Cash Flow	-7.74M
Capital Expenditures	-195,033
Free Cash Flow	-7.93M
FCF Per Share	-$0.55

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NanoViricides does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.11%
Shareholder Yield	-6.11%
Earnings Yield	-44.22%
FCF Yield	-37.11%

Analyst Forecast

The average price target for NanoViricides is $6.50, which is 336.24% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.50
Price Target Difference	336.24%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on September 24, 2019. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Sep 24, 2019
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1